Cargando…

Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage

Detalles Bibliográficos
Autores principales:	Lebourgeois, Samuel, Menidjel, Reyene, Chenane, Houssem Redha, Ferré, Valentine Marie, Collin, Gilles, Damond, Florence, Coppée, Romain, Yazdanpanah, Yazdan, Timsit, Jean-François, Houhou-Fidouh, Nadhira, Descamps, Diane, Charpentier, Charlotte, Visseaux, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603409/ https://www.ncbi.nlm.nih.gov/pubmed/34808243 http://dx.doi.org/10.1016/j.jinf.2021.11.012

Ejemplares similares

Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
por: Lebourgeois, Samuel, et al.
Publicado: (2021)

Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Differential activation of human neutrophils by SARS-CoV-2 variants of concern
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study
por: Loubet, Paul, et al.
Publicado: (2017)

Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021
por: Coppée, Romain, et al.
Publicado: (2022)

Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016
por: Visseaux, Benoit, et al.
Publicado: (2017)

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient
por: Michiels, Yves, et al.
Publicado: (2021)

Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
por: Visseaux, Benoit, et al.
Publicado: (2021)

Genome Sequence of an Early Imported Case of SARS-CoV-2 Delta Variant (B.1.617.2 AY.122) in Iraq in April 2021
por: Al-Rashedi, Nihad A. M., et al.
Publicado: (2022)

Genetic emergence of B.1.617.2 in COVID-19
por: Kirola, L.
Publicado: (2021)

SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic wave
por: Azami, Nor Azila Muhammad, et al.
Publicado: (2022)

Analysis of the Delta Variant B.1.617.2 COVID-19
por: Shiehzadegan, Shayan, et al.
Publicado: (2021)

Genome Sequences of the Delta Variant (B.1.617.2) and the Kappa Variant (B.1.617.1) Detected in Morocco
por: Melloul, Marouane, et al.
Publicado: (2021)

Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia
por: Voiriot, Guillaume, et al.
Publicado: (2016)

Structural Evolution of Delta (B.1.617.2) and Omicron (BA.1) Spike Glycoproteins
por: Prandi, Ingrid Guarnetti, et al.
Publicado: (2022)

Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)

Vaccine effectiveness against the B.1.617.2 in the intensive care unit
por: Koc, Ibrahim, et al.
Publicado: (2023)

Multiple partition Markov model for B.1.1.7, B.1.351, B.1.617.2, and P.1 variants of SARS-CoV 2 virus
por: García, Jesús Enrique, et al.
Publicado: (2022)

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2022)

Effect of COVID-19 Delta (B.1.617.2) and Omicron (B.1.1.529) surges on emergency medicine physician compassion
por: Bowling, John M., et al.
Publicado: (2022)

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Case report study of the first five COVID-19 patients treated with remdesivir in France
por: Dubert, Marie, et al.
Publicado: (2020)

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
por: Ren, Wenlin, et al.
Publicado: (2022)

Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study
por: Bouzid, Donia, et al.
Publicado: (2023)

The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
por: Cai, Changjing, et al.
Publicado: (2021)

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
por: Lopez Bernal, Jamie, et al.
Publicado: (2021)

Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers
por: Kemp, Steven A., et al.
Publicado: (2022)

Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021
por: Lassaunière, Ria, et al.
Publicado: (2021)

COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2
por: Kumar, Nitya, et al.
Publicado: (2022)

COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods
por: Al Hasan, Syed Mahfuz, et al.
Publicado: (2022)

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
por: Wall, Emma C, et al.
Publicado: (2021)

Relationships between COVID-19 healthcare outcomes and county characteristics in the U.S. for Delta (B.1.617.2) and Omicron (B.1.1.529 and BA.1.1) variants
por: Bruckhaus, Alexander A., et al.
Publicado: (2023)

Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge
por: Adhikari, Emily H., et al.
Publicado: (2022)

Serial intervals in SARS-CoV-2 B.1.617.2 variant cases
por: Pung, Rachael, et al.
Publicado: (2021)

Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
por: Arora, Prerna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cto034hltam6odn6nghqbt6sqt